MARKET

SNSE

SNSE

Sensei Biotherapeutics, Inc.
NASDAQ
0.3999
-0.1084
-21.33%
Opening 14:04 03/31 EDT
OPEN
0.4250
PREV CLOSE
0.5083
HIGH
0.4998
LOW
0.2500
VOLUME
3.81M
TURNOVER
--
52 WEEK HIGH
1.940
52 WEEK LOW
0.2500
MARKET CAP
10.06M
P/E (TTM)
-0.3364
1D
5D
1M
3M
1Y
5Y
1D
Biotech Alert: Searches spiking for these stocks today
TipRanks · 1h ago
Weekly Report: what happened at SNSE last week (0324-0328)?
Weekly Report · 5h ago
Sensei Biotherapeutics (SNSE) Gets a Buy from Oppenheimer
TipRanks · 1d ago
Sensei Biotherapeutics Reports Promising 2024 Results
TipRanks · 2d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga · 3d ago
Sensei Biotherapeutics GAAP EPS of -$1.20
Seeking Alpha · 3d ago
Sensei Biotherapeutics Reports Favorable Initial Clinical Activity Data For Solnerstotug In Resistant Tumors
Benzinga · 3d ago
Sensei Biotherapeutics Is Maintained at Outperform by Oppenheimer
Dow Jones · 3d ago
More
About SNSE
More
Sensei Biotherapeutics, Inc. is a clinical-stage immuno-oncology company, which is focused on the discovery and development of therapeutics for cancer patients. Through its Tumor Microenvironment Activated biologics (TMAb) platform, the Company develops conditionally active therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment to unleash T cells against tumors. Its lead investigational candidate is SNS-101, a conditionally active antibody designed to block the V-domain Ig suppressor of T cell activation checkpoint selectively within the low pH tumor microenvironment. It is also developing SNS-102, a conditionally active monoclonal antibody targeting V-Set and Immunoglobulin Domain Containing 4 (VSIG-4); SNS-103, a conditionally active monoclonal antibody targeting ecto-nucleoside triphosphate diphosphohydrolase-1 (ENTPDase1), CD39; and SNS-201, a conditionally active VISTAxCD28 bispecific antibody.
Recently
Symbol
Price
%Change

Webull offers Sensei Biotherapeutics Inc stock information, including NASDAQ: SNSE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNSE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNSE stock methods without spending real money on the virtual paper trading platform.